Philip Chang, MD
Assistant Professor, Neurology
Biography
My clinical services include serving as a neuro-hospitalist at and as a regional telestroke neurologist for Northern California since 8/2018. I am involved with regional conferences to discuss potential PFO closures. Besides my current clinical duties, I am involved in local and regional efforts to improve delivery of acute stroke therapies to patients in the northern California Permanente Medical Group. I am involved in medical student and resident teaching. In addition, I am also involved in the implementation and usage of Ceribell, an EEG-headband to improve treatment times of status epilepticus. In addition, I am a member of the American Heart Association and the American Academy of Neurology.
Given the rocky trial history of both alteplase and thrombectomy in acute stroke care, I have had a great interest in trial design and application of clinical trials in acute stroke care. In this purpose, I am a reviewer for the stroke council in the American Stroke Association for the journal Stroke. In addition, I am a contributor of “Blogging Stroke”, an American Stroke Association to popularize and inform the community about recent advances in stroke, along with personal interpretations of recent major clinical trials in a contemporary and accessible manner to the millennial generation.
Other Positions
- Kaiser Permanente Santa Clara Medical Center
Websites
Education
- Northwestern University School of Medicine, MD
- Northwestern University, BA
Publications
- Published on 6/1/2020
Wang K, Luo J, Yeh S, You B, Meng J, Chang P, Niu Y, Li G, Lu C, Zhu Y, Antonarakis ES, Luo J, Huang CP, Xu W, Chang C. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nat Commun. 2020 06 01; 11(1):2689. PMID: 32483206.
Read at: PubMed - Published on 1/1/2019
Chang P, Bernstein RA. CURRENT Diagnosis & Treatment Neurology (John C.M. Brust ed.). Cerebrovascular Disease: Hemorrhagic Stroke. McGraw-Hill Education. 2019; 120-145.
- Published on 12/1/2018
Chang P, Ruff I, Mendelson SJ, Caprio F, Bergman DL, Prabhakaran S. The 2CAN Score. Stroke. 2018 12; 49(12):2866-2871. PMID: 30571426.
Read at: PubMed - Published on 4/13/2017
Chang P, Prabhakaran S. Recent advances in the management of acute ischemic stroke. F1000Res. 2017; 6. PMID: 28491278.
Read at: PubMed - Published on 7/25/2012
Lai JJ, Chang P, Lai KP, Chen L, Chang C. The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res. 2012 Sep; 304(7):499-510. PMID: 22829074.
Read at: PubMed - Published on 7/24/2012
Chang P, Saddleton E, Laumann AE, Schmitz B, West DP, Belknap SM, Parthasarathy S, Edwards BJ, McKoy JM, Miller FH. Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function. Acad Radiol. 2012 Oct; 19(10):1181-5. PMID: 22831822.
Read at: PubMed - Published on 11/9/2009
Lai JJ, Lai KP, Chuang KH, Chang P, Yu IC, Lin WJ, Chang C. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest. 2009 Dec; 119(12):3739-51. PMID: 19907077.
Read at: PubMed - Published on 1/1/2007
Chang E, Ni J, Yin Y, Lin CC, Chang P, James NS, Chemler SR, Yeh S. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells. Asian J Androl. 2007 Jan; 9(1):31-9. PMID: 17187157.
Read at: PubMed - Published on 9/1/2006
Marshall KL, Painter G, Lotito K, Noto AG, Chang P. Transition Metal Dithiolene Near-IR Dyes and Their Applications in Liquid Crystal Devices. Molecular Crystals and Liquid Crystals. 2006; 1(454):47-79.
- Published on 3/1/2006
Chang P, Noto AG, Marshall KL. Application of Computational Chemistry Methods to the Prediction of Electronic Structure in Nickel Dithiolene Complexes. University of Rochester’s Laboratory for Laser Energetics Lab Student Reports. 2006; (343):13-19.
View 2 more publications: View full profile at BUMC